Navigation Links
BioMedix Receives Clinical Approval for TRAKnet Software
Date:4/27/2010

ST. PAUL, Minn., April 27 /PRNewswire/ -- Today, the BioMedix TRAKnet software suite was granted the prestigious American Podiatric Medical Association (APMA) Seal of Acceptance. BioMedix is the only company to receive the APMA Seal of Acceptance for Electronic Health Record and Practice Management software.

"TRAKnet is an invaluable tool for our member podiatrists because it integrates day to day activities such as electronic health records, charting, scheduling and billing into one comprehensive system," said APMA President Kathleen Stone, DPM. "The system also helps our members take advantage of federal incentives offered to physicians using electronic medical records."

TRAKnet Electronic Health Record and Practice Management software is an expandable, all-in-one practice management platform that enables seamless operation and increased efficiency while reducing costs. Designed by and for podiatric physicians, the software incorporates billing, charting, scheduling, e-prescribing and inventory management to allow effortless transition from scheduling to encounters and claims while interfacing with the BioMedix full suite of software and hardware products that enable physician offices, vascular labs and hospitals to deliver community based collaborative care.

Established more than 35 years ago, the American Podiatric Medical Association (APMA) Seal Program was created to inform both podiatric physicians and consumers about products whose quality, safety, and effectiveness allow for normal foot function and/or promote quality foot health. The APMA Seal of Acceptance is awarded to equipment for professional use in the delivery of foot care when evidence of safety and effectiveness has been established by an appropriately recognized laboratory and/or clinical investigation and/or when physical standards and/or specifications applicable to equipment have been met.

John Romans, BioMedix President and CEO comments, "It is always a great honor to receive clinical approval from a national physician association. Receiving the APMA's Seal of Acceptance for TRAKnet, however, is particularly special as we are committed at BioMedix to making healthcare information technology more accessible to the podiatric physician community so they may better serve patients in critical need of their care."

About BioMedix

BioMedix Vascular Solutions, Inc. provides the only integrated suite of hardware, software and online services designed to cost-effectively detect Peripheral Arterial Disease (P.A.D.) and Chronic Venous Insufficiency (CVI). Vascular specialists, primary care providers, hospitals and health systems use our products to identify these patients. Our devices and Health Information Technology (HIT) software reduce mistakes, provide data for sound analysis, build practice revenue and streamline reimbursement while providing a platform that supports the continuum of care and increased quality outcomes. For more information, call 877-854-0014 or log on to www.BioMedix.com.

About the American Podiatric Medical Association

Founded in 1912, the American Podiatric Medical Association (APMA), headquartered in Bethesda, Maryland, is the leading resource for foot and ankle health information. Currently, the organization represents a vast majority of the estimated 15,000 podiatrists in the country. In addition to the national headquarters, APMA boasts 53 state component locations throughout the United States and its territories, as well as affiliated societies. For free foot health information, contact APMA at 1-800-FOOTCARE (1-800-366-8227) or visit www.apma.org on the web.


'/>"/>
SOURCE BioMedix Vascular Solutions, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Shire Receives INTUNIV(TM) Paragraph IV Notice Letter From Anchen
2. Flexuspine Receives FDA Conditional Approval to Begin a Feasibility Study of Its FSU (Functional Spinal Unit) Total Spine Arthroplasty System in the United States
3. Palatin Technologies, Inc. Receives $2.5 Million from AstraZeneca
4. ATS Medical Receives Approval to Commercialize the ATS Simulus Annuloplasty Products in Canada
5. Actavis Receives Approval of Alprazolam ODT in the U.S.
6. Epeius Biotechnologies Receives Notice of Patent Allowance for Tumor-Targeted Cancer Vaccines
7. Watson Receives FDA Approval for Generic Cardizem(R) LA
8. ADVENTRX Receives Brand Name Acceptance for ANX-530
9. CEL-SCI Receives Payment From Marketing Partner
10. International Growth Continues: Rhythmlink International, LLC Receives CE Marking & ISO 13485 Certification
11. ISTA Pharmaceuticals Receives Action Date for FDA Review of Once-Daily XiDay(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... Dec. 8, 2016  EIP Pharma, LLC ( ... proof-of-mechanism for neflamapimod (previously code named VX-745), with ... clinical trials that demonstrated significant Alzheimer,s disease relevant ... treatment) and Study 303 (6-week treatment) are the ... Alzheimer,s Disease (CTAD) scientific conference in ...
(Date:12/8/2016)... A Small Business Innovative Research (SBIR) grant ... (NIH) to Phoenix -based NeuroEM Therapeutics, ... grant will seek to determine an optimal set of ... waves to treat Alzheimer,s Disease. The grant will also ... treat other neurologic disorders such as Parkinson,s Disease and ...
(Date:12/8/2016)... New York , December 8, 2016 ... global Diabetes Injection Pens Market is expected to ... compared to US$4.9 bn in 2015. Between the forecast years ... rise at a CAGR of 7.9%. The leading players operating ... A/S, Eli Lilly and Company, AstraZaneca plc., Biocon Ltd., and ...
Breaking Medicine Technology:
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... Donuts Franchising Company LLC, announced the first national #QuackGivesBack campaign which supported ... , “This was our first franchise-wide Quack Gives Back initiative, and ...
(Date:12/8/2016)... ... ... CURE Media Group, the nation’s leading digital and print media enterprise focused ... in efforts to combat lung cancer, announced CURE Media Group President Michael J. Hennessy, ... is honored to team up with Upstage Lung Cancer in order to make major ...
(Date:12/8/2016)... ... December 08, 2016 , ... SunView ... customers and employees that are both engaging and easy to use. Coming off ... the software company revealed today its plans to roll out new AI-powered self-service ...
(Date:12/8/2016)... ... , ... STAT courier is pleased to announce that due to customer demand, ... expanding their presence in Dallas. One of the most exciting parts for STAT is ... the Dallas and Forth Worth market. STAT takes pride in treating their employees with ...
(Date:12/8/2016)... ... 08, 2016 , ... Vida Health, the digital health platform that ... Canvas Ventures . Other investors include Nokia Growth Partners (NGP) and returning investor ... more consumers who are managing chronic conditions or simply want to improve ...
Breaking Medicine News(10 mins):